Biochemical changes in patients with combined chronic schistosomiasis and viral hepatitis C infections

Disease Markers

Volumn 16, Issue 3-4, 2000, Pages 111-118

  Fahim, Fawzia A ^a   Esmat, Amr Y ^a   Hassan, Gehan K ^b   Abdel Bary, Abeer ^b  

^a Ain Shams University   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Biochemistry; Hepatitis C; Schistosomiasis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; GAMMA GLUTAMYLTRANSFERASE; IRON; MAGNESIUM; PROTEIN; UREA;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HEPATOSPLENOMEGALY; HUMAN; LIVER CIRRHOSIS; MALE; PATIENT CODING; PRIORITY JOURNAL; SCHISTOSOMIASIS; STANDARD; VIRUS HEPATITIS; VIRUS PATHOGENESIS;

DNA VIRUSES; HEPATITIS C VIRUS; PROTOZOA;

EID: 0034436882     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/732754     Document Type: Article

References (46)

1. Causes of minimal hepatic periportal fibrosis present in Egypt
2. Cytophotometric estimation of hepatocytes DNA in chronic liver diseases including schistosomiasis for detection of early preneoplastic changes
3. Serum prealbumin in schistosomiasis
4. Experimental schistosomiasis mansoni: Electrophoretic studies on serum proteins before and after administration of Oxamniquine
5. Quantitative determination of iron in serum
6. Capillary electrophoresis
7. Liver functions
8. Prospects of vaccination against schistosomiasis
9. Kinetics of classes and subclasses of total immunoglobulins and specific antibodies to S. Mansoni during murine infection
10. Enzyme diagnosis in hepatic disease
11. High seroprevalence of hepatitis A, B, C and E viruses in residents in an Egyptian village in the Nile Delta
12. Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors
13. Schistosomiasis
14. Clinical and pharmacokinetic study of praziquantel in Egyptian schistosomiasis patients with and without liver cell failure
15. Immunoelectrophoretic studies on serum proteins in bilharzial patients
16. Delta virus versus HBsAg in chronic active hepatitis and their relation to clinical, laboratory and morbidity findings in bilharzial and non bilharzial patients
17. Evaluation of serum cholinesterase and albumin in bilharziasis
18. Serum gamma- glutamyltranspeptidase activity in hepatosplenic schistosomiasis
19. The prevalence of hepatitis C and infections among immigrants to a newly reclaimed area endemic for schistosoma mansoni in Sinai
20. Does schistosomiasis play a role in the high seroprevalence of HCV antibody among Egyptians
21. History of hepatic lesion: Schistosoma mansoni bilharziasis
22. Serologic reaction in S mansoni infections III. Ionographic fractionation of sera of mice with progressive disease
23. Hepatocyte proliferative activity in chronic liver damage as assessed by the monoclonal antibody MIBI Ki67 in archival material: The role of etiology, disease activity, iron and lipid peroxidation
24. Immunopathology of hepatitis C
25. Assessment of liver functions in bilharzial hepatic fibrosis
26. Quantitative determination of magnesium in serum
27. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients
28. The epidemiology of antibody to hepatitis C in Egypt
29. Quantitative determination of total protein concentration in serum or plasma by a timed-endpoint Biuret method
30. Liver and biliary diseases
31. Colorimetric determination of serum plasma total and direct bilirubin
32. Hepatitis C virus-associated glomerulo-nephritis, effect of alpha interferon
33. Laboratory tests
34. The clinical behaviour of immunology unique courses of NANB hepatitis
35. Gastric histochemical studies in endemic schistosomal hepatosple-nomegaly
36. Abnormal liver function tests in asymptomatic patients
37. Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity
38. Serum aminotransferase levels and histological disease in chronic hepatitis C
39. Serum glycoproteins in schistoso-miasis
40. Clinical evaluation of liver function
41. The pathology of hepatitis C
42. Virus Hepatitis
43. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
44. Estimation of hemoglobin by the determination of blood total iron